Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin in patients with polycystic ovary syndrome
IRCT20250429065525N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of astaxanthin in polycystic ovary syndrome (PCOS), sponsored by Tehran University of Medical Sciences. Started Jul 2025; status: completed.
02
Drugs
astaxanthin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20250429065525N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250429065525N1.